Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT04745351Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT04843761ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
NCT04694612Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal